Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVTX | AMGN | VRTX | REGN | GILD |
| Company | Travere Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.90 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 10.17 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 9.59 | 332.47 | 491.52 | 1,065.62 | 72.02 |
| Last | 9.47 | 333.72 | 491.99 | 1,065.64 | 72.50 |
| Change | -0.33 | +2.43 | +0.42 | +2.04 | -0.06 |
| % Change | -3.37% | +0.73% | +0.09% | +0.19% | -0.08% |
| Volume | 84,425 | 384,219 | 273,875 | 71,118 | 1,009,904 |
| 20-Day Average Volume | 1,181,858 | 2,020,391 | 1,103,860 | 414,294 | 6,282,834 |
| Previous Close | 9.80 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.98 | 320.97 | 481.73 | 1,064.43 | 69.80 |
| 20-Day Raw Stochastic | 76.35% | 87.02% | 80.95% | 62.90% | 74.97% |
| 20-Day Relative Strength | 65.74% | 67.87% | 66.02% | 58.15% | 63.60% |
| Weighted Alpha | -15.19 | +41.36 | +42.97 | +42.58 | -4.29 |
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.12% since 07/15/24 | +1.38% since 07/15/24 | +0.34% since 07/15/24 | -1.02% since 07/15/24 | +2.65% since 07/15/24 |
| Low | 9.56 on 07/19/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 10.43 on 07/16/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +32.69% since 06/21/24 | +8.62% since 06/21/24 | +5.08% since 06/21/24 | +1.71% since 06/21/24 | +2.86% since 06/21/24 |
| Low | 7.36 on 06/24/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 10.43 on 07/16/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +65.81% since 04/22/24 | +23.10% since 04/22/24 | +23.16% since 04/22/24 | +18.99% since 04/22/24 | +8.57% since 04/22/24 |
| Low | 5.12 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 10.43 on 07/16/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +9.60% since 01/22/24 | +7.92% since 01/22/24 | +11.91% since 01/22/24 | +13.60% since 01/22/24 | -7.32% since 01/22/24 |
| Low | 5.12 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 10.43 on 07/16/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 746,064 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 76,129 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 145,240,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -111,400,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 41,370,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -136,060,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.77 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.76 on 05/06/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |